Dr. Reddy's Laboratories Limited (DRREDDY) secures marketing authorization for generic semaglutide injection in Brazil, expanding its diabetes treatment opti.
Aurobindo Pharma Limited (NSE: AUROPHARMA) announced consolidated financial results for Q2FY27 with a record revenue of INR 10,263 Cr.
Krishna Institute of Medical Sciences Limited (KIMS) reports Q2 FY27 results with revenue up 41% YoY and PAT surging 104%.
SMS Pharmaceuticals Limited (NSE: SMSPHARMA) reports a 30% YoY revenue growth and a 57% increase in PAT for Q2FY27, driven by strong volume growth and improv.
Lenskart Solutions Limited (LENSKART) Q2 FY27: Profit after tax more than doubles to ₹232 crore, revenue up 32.5%.
Biocon Limited's Q2 FY27 results show a 2% revenue increase, with EBITDA margin decline; strong biosimilars and generics performance.
Alembic Pharmaceuticals Limited (APLLTD) reports strong Q2 FY27 performance with revenue up 36% and PAT up 81% YoY.
Dr. Lal Path Labs Ltd. (LALPATHLAB) reports a 19.6% revenue growth and 27.5% PAT increase in Q2 FY27.
Marksans Pharma Limited (MARKSANS) reports record Q2 & H1 FY27 results with revenue crossing ₹900 crore and PAT nearly doubling.
Biocon Limited (BIOCON) reports Q2FY27 total income at Rs 4,423 Cr, up 1% YoY. Biopharma revenue up 5%.